Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE 11.12 (2016).
- Schlagwort
-
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2016
- Urheber
-
Dammers, Christina
Yolcu, Deniz
Kukuk, Laura
Willbold, Dieter
Pickhardt, Marcus
Mandelkow, Eckhard
Horn, Anselm H. C.
Sticht, Heinrich
Malhis, Marwa Nidal
Will, Nadja
Schuster, Judith
Funke, Susanne Aileen
- URN
-
urn:nbn:de:bvb:29-opus4-81323
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dammers, Christina
- Yolcu, Deniz
- Kukuk, Laura
- Willbold, Dieter
- Pickhardt, Marcus
- Mandelkow, Eckhard
- Horn, Anselm H. C.
- Sticht, Heinrich
- Malhis, Marwa Nidal
- Will, Nadja
- Schuster, Judith
- Funke, Susanne Aileen
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2016
Ähnliche Objekte (12)
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Synthetic Peptides as Protein Mimics
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer's Disease?
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Exploring Stability, Dynamics and Interactions of Microbial Effectors and Host Proteins: A Computational Approach
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Synthetic Peptides as Protein Mimics
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer's Disease?
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Exploring Stability, Dynamics and Interactions of Microbial Effectors and Host Proteins: A Computational Approach
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Synthetic Peptides as Protein Mimics
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer's Disease?
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell